| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/04/2006 | US7071318 Comprises nucleotide sequences coding muscle ring finger protein (MURF) for use in identifying modulators which can be used to diagnose and treat cardiomyopathies |
| 07/04/2006 | US7071317 Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods |
| 07/04/2006 | US7071315 Alleles of the human mu opioid receptor, diagnostic methods using said alleles, and methods of treatment based thereon |
| 07/04/2006 | US7071312 Epidermal differentiation factor |
| 07/04/2006 | US7071309 Determination metastasis using protein |
| 07/04/2006 | US7071308 Cytokine receptor |
| 07/04/2006 | US7071306 AMPA-binding human GluR4 receptors |
| 07/04/2006 | US7071305 Human transport protein; brain and kidney analysis; animal models; drug screening; nephrotoxicity; removal of toxic anions from circulatory system |
| 07/04/2006 | US7071303 Androgen regulated prostate specific nucleic acids |
| 07/04/2006 | US7071302 Isolated protein, and amino acid sequence thereof from caenorhabditis elegans genes ced-3 and ced-4 |
| 07/04/2006 | US7071301 Supplying vector; amino acid sequence for binding virus; modifying sequence for binding second virus; genetic engineered polypeptide |
| 07/04/2006 | US7071300 IGF antagonist peptides |
| 07/04/2006 | US7071299 For therapy of conditions characterized by inappropriate complement activation; for therapy of adult respiratory distress syndrome, ischemia-reperfusion injury, hyperacute rejection (transplantation), sepsis, cardiopulmonary bypass |
| 07/04/2006 | US7071297 Tolerogenic peptides from myelin basic protein |
| 07/04/2006 | US7071296 vaccines against malaria comprising epitopes contained within merozoite surface proteins (MSP) or polypeptides, and carriers such as alums and/or freund's adjuvants; inoculation; immunology |
| 07/04/2006 | US7071295 Signal for targeting molecules to the sarco(endo)plasmic reticulum |
| 07/04/2006 | US7071294 Tumor antigen protein art-1 and tumor antigen peptide thereof |
| 07/04/2006 | US7071293 Protein; biological antigrowth agent; bactericides |
| 07/04/2006 | US7071164 Matrix metalloproteinases inhibitor peptides having sequences related to cleavage regions of the proenzyme forms of matrix |
| 07/04/2006 | US7071163 Compounds for targeting hepatocytes in vivo |
| 07/04/2006 | US7071161 Variants of corticotropin releasing hormone receptor Type 1 and uses thereof |
| 07/04/2006 | US7071160 Integrin binding polipeptide for diagnosis, prevention and treatment of renal failure, thrombosis, osteoporosis, cancers and diabetes |
| 07/04/2006 | US7071159 Solubility forms; skin disorders, rheumatic disorders, antidiabetic agents |
| 07/04/2006 | US7070998 Supplying Dna to cells; genetic engineering genomes; therapy for central nervous system diosrders |
| 07/04/2006 | US7070997 Controlling gene expression, apoptosis in plants |
| 07/04/2006 | US7070995 CE7-specific redirected immune cells |
| 07/04/2006 | US7070994 genetic engineered retrovirus; from transgenic animals; drug transport |
| 07/04/2006 | US7070993 Lentiviral packaging constructs |
| 07/04/2006 | US7070992 Improved efficiency of gene expression |
| 07/04/2006 | US7070991 Cells expressing a CD4-IgG2 chimeric heterotetramer |
| 07/04/2006 | US7070989 Genetic engineered plasmid vectors; antibiotic resistance; anticancer agents |
| 07/04/2006 | US7070982 Bacillus chimeric crystal protein with enhanced insecticidal for use in generating and propagating insect resistant plants; biological control agents; pest control |
| 07/04/2006 | US7070981 Gene 763 of phytopathogenic fungus Magnaporthe grisea and use thereof for identifying fungicidal compounds |
| 07/04/2006 | US7070978 Expression of preferential protein in in culture; obtain cell, transfrom with vecro containg preferential protein, express vector, lyse cell, recover protein |
| 07/04/2006 | US7070972 Isolated polynucleotide; catalyst; transformation lymphocytes; antibodies; detecting therapy agents |
| 07/04/2006 | US7070969 Plasmin inhibitors from the australian brown snake Pseudonaja textilis textilis |
| 07/04/2006 | US7070959 Prevent blood leakage or vacular system permeability; isolated nucleic acid; fusion protein containing endothelial growth factor and immunoglobulins |
| 07/04/2006 | US7070957 STARS—a muscle-specific actin-binding protein |
| 07/04/2006 | US7070956 Peptides and derivatives thereof showing cell attachment, spreading and detachment activity |
| 07/04/2006 | US7070955 Comprises nucleotide sequences coding membrane proteins for diagnosing, preventing and treating inflammatory, cell proliferative and autoimmune diseases |
| 07/04/2006 | US7070946 Polypeptide for use in the diagnosis and treatment of bone disorders |
| 07/04/2006 | US7070940 Method for determining the ability of a compound to modify the interaction between parkin and the p38 protein |
| 07/04/2006 | US7070939 Methods for detecting vasculopathies and tumors |
| 07/04/2006 | US7070938 Measuring activity of endothelial growth factor modulator; obtain modulator, incubate with kinase, isolate phosphorylated substrate, remove label, detecting adjustment in kinase activity |
| 07/04/2006 | US7070931 Controlling gene expression; calibration |
| 07/04/2006 | US7070929 Genetic markers for improved disease resistance in animals (BPI) |
| 07/04/2006 | US7070926 Chimaeric phages |
| 07/04/2006 | US7070807 Administering polypeptide by injection; gene therapy |
| 07/04/2006 | US7070794 is a mixture having an amino acid, peptide, and/or protein fragment molecular weight range of 200 880,000 daltons and having high simmondsin concentration |
| 07/04/2006 | US7070793 Antigen protein and nucleic acid coding for said protein |
| 07/04/2006 | US7070792 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 07/04/2006 | US7070791 Comprises genetically engineered bacteriophage polymerase for detection and treatment of microorganismal infections |
| 07/04/2006 | US7070790 peptides and recombinant envelope 1 and core proteins derived from specific gene sequences and their use in diagnostic methods and vaccines. |
| 07/04/2006 | US7070789 Hybrid polypeptides as vaccine |
| 07/04/2006 | US7070788 Adjusted glycoprotein; for use in treatment of cancer |
| 07/04/2006 | US7070787 Relates to immunogen for inducing antibodies that neutralize a wide spectrum of HIV primary isolates and method of inducing anti-HIV antibodies using such immunogen |
| 07/04/2006 | US7070785 Heat shock proteins for use in enhancing cellular factor production |
| 07/04/2006 | US7070784 Method for down-regulating GDF-8 activity using immunogenic GDF-8 analogues |
| 07/04/2006 | US7070783 DNA having a specific sequence encoding a receptor molecule that binds to tumor necrosis factor comprising two extracellular domains of tumor necrosis factor receptors linked to a polypeptide linker, which is covalently bonded to said extracellular domains via peptide bonds; autoimmune diseases and IBDs |
| 07/04/2006 | US7070782 Prostate-specific membrane antigen |
| 07/04/2006 | US7070781 Nontoxic mucosal adjuvant |
| 07/04/2006 | US7070780 Treatment of demyelinating autoimmune disease with ordered peptides |
| 07/04/2006 | US7070779 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis, and bordetella bronchiseptica, their use in diagnostics, and in immunogenic compositions |
| 07/04/2006 | US7070776 inhibiting an immune response by reacting B7 positive cells with an antibody which binds with B7 antigen having a specific amino acid sequence |
| 07/04/2006 | US7070775 Recombinant A2-specific TNFα specific antibodies |
| 07/04/2006 | US7070774 Antibodies that bind testis-specific insulin homolog polypeptides |
| 07/04/2006 | US7070771 Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells |
| 07/04/2006 | CA2396674C Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein |
| 07/04/2006 | CA2260870C Phytofluors as fluorescent labels |
| 07/04/2006 | CA2228956C Cdna corresponding to the antigenome of nonsegmented negative strand rna viruses, and process for the production of such viruses encoding additional antigenically active proteins |
| 07/04/2006 | CA2205359C Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-beta peptide (x->=41) and tau |
| 06/29/2006 | WO2006069403A2 Methods for producing soluble multi-membrane-spanning proteins |
| 06/29/2006 | WO2006069306A2 A knockout mouse for the tumor suppressor gene anx7 |
| 06/29/2006 | WO2006069262A2 Compositions of influenza viral proteins and methods of use thereof |
| 06/29/2006 | WO2006069253A2 Trefoil factors and methods of treating proliferation disorders using same |
| 06/29/2006 | WO2006069220A2 Modified human growth hormone |
| 06/29/2006 | WO2006069029A1 Purified rhigf-i/rhigfbp-3 complexes and their method of manufacture |
| 06/29/2006 | WO2006068910A1 Glp-1 analog fusion protein formulations |
| 06/29/2006 | WO2006068867A1 Combination therapy for b cell disorders |
| 06/29/2006 | WO2006068625A1 Novel snake toxin |
| 06/29/2006 | WO2006068440A1 Human cancer suppressor gene, protein encoded therein, expression vector containing the same, and cell transformed by the vector |
| 06/29/2006 | WO2006068398A1 Molecules inhibition intercellular adhesion |
| 06/29/2006 | WO2006068326A1 Novel polypeptide and the use thereof |
| 06/29/2006 | WO2006068250A1 Nanographite structure/metal nanoparticle composite |
| 06/29/2006 | WO2006068187A1 Target physiological function inactivator using photosensitizer-labeled fluorescent protein |
| 06/29/2006 | WO2006067913A1 Method of preparing antibody by use of cell having its fucose transporter function inhibited |
| 06/29/2006 | WO2006067847A1 Method of preparing antibody by use of cell having its fucose transporter function inhibited |
| 06/29/2006 | WO2006067793A1 Low cell density fermentation process for the production of heterologous recombinant proteins in microorganisms |
| 06/29/2006 | WO2006067565A2 Truncated gabab receptor and methods of use thereof |
| 06/29/2006 | WO2006067506A2 Hiv resistance genes |
| 06/29/2006 | WO2006067406A1 Immunomodulatory peptide fragments of cd23 and uses therefor |
| 06/29/2006 | WO2006067402A2 Agents inibiting the cathelin-like protein cap18/ll-37 |
| 06/29/2006 | WO2006067230A1 Reduction of the content of protein contaminants in compositions comprising a vitamin k-dependent protein of interest |
| 06/29/2006 | WO2006067210A1 Bcma polypeptides and uses thereof |
| 06/29/2006 | WO2006067170A1 G-csf polypeptides and uses thereof |
| 06/29/2006 | WO2006067145A1 New mannoprotein with full solubility in wine and its application in the stabilisation of wine |
| 06/29/2006 | WO2006067116A1 Expression of gamma-carboxylated polypeptides in gamma-carboxylation deficient host systems |
| 06/29/2006 | WO2006067094A1 Method for isolating neural cells using tenascin-r compounds |
| 06/29/2006 | WO2006067091A1 Myd88 homodimerization inhibitors |
| 06/29/2006 | WO2006067063A2 Screening methods for identification of modulators of cytokine class i |